They wanted to see if the observed anti-inflammatory effects of cannabis also affect the development of liver disease. The study was led by Adeyinka Charles Adejumo of North Shore Medical Center in Salem, Massachusetts
DetailsThe findings sounded alarming. But like any study, this one had key limitations, including the fact that it defined cannabis “users” as anyone who’d ever tried the drug. More importantly, however, it highlighted an important gap in our current understanding of the science of cannabis:
DetailsAdvocates for medical marijuana have tried and failed in Virginia year after year. A few years ago, they persuaded lawmakers to allow it for epilepsy.
DetailsThe trial reduced the frequency of seizures in patients with the illness, just 10% of whom had previously been found to respond to conventional drug treatments, though the authors say that efficacy and safety of the new treatment ‘now needs to be confirmed’.
Details
